ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,718,949, issued on Aug. 25, was assigned to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (paris), KATHOLIEKE UNIVERSITEIT LEUVEN (Leuven, Belgium), CENTRE HOSPITALIER ET UNIVERSITAIRE DE LIMOGES (Limoges, France) and UNIVERSITE DE LIMOGES (Limoges, France).

"Computer-implemented diagnostic method for determining the clinical interpretation of renal graft alterations" was invented by Pierre Marquet (Limoges, France), Marc Labriffe (Limoges, France), Dany Anglicheau (Paris), Wilfried Gwinner (Hannover, Germany) and Maarten Naesens (Leuven, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a computer-impl...